JAKARTA, June 28 (Xinhua) -- Eight hospitals in Indonesia are set to conduct clinical trials on Ivermectin, an anti-parasitic medicine that has appeared to be a potential COVID-19 medication, following a permit issued by the national agency of drug and food control (BPOM).
BPOM's head Penny K. Lukito said at a press conference on Monday that global data and guidelines from the World Health Organization (WHO) show that Ivermectin, previously used for deworming, can also be used for COVID-19 treatment. However, data are still being collected and the results are not conclusive.
Clinical trials are expected to be conducted over a period of three months.
Lukito has called on the public not to take this medicine freely considering that Ivermectin must be prescribed by doctors. Enditem